Vectura News

Discover more about our company, science, innovation and people with the latest headlines from Vectura.

Displaying 12 of 68

Vectura signs agreement with Kinaset Therapeutics Inc. to support the development of VR588 to treat asthma

Published30/11/2020

Read more
Vectura provides update on GSK litigation

Published19/11/2020

Read more
Will Downie’s podcast: “There’s a patient at the end of every piece of work we do…”

Published08/10/2020

Read more
Vectura shortlisted for ’Excellence in Pharma: Contract Services and Outsourcing’

Published24/09/2020

Read more
Status update on VR315 (US)

Published22/09/2020

Read more
2020 Interim Results

Published15/09/2020

Read more
Vectura partners with Monash University to support development of inhaled oxytocin to prevent postpartum haemorrhage

Published14/09/2020

Read more
Notice of Interim Results

Published06/08/2020

Read more
QVM149 receives regulatory approval in Europe and Japan

Published07/07/2020

Read more
Live Webcast 24th June: Dry Powder Inhalers – Key Considerations for Combination Product Development

Published17/06/2020

Read more
Vectura signs agreement with Aerami Therapeutics Inc.

Published08/06/2020

Read more
Vectura expands business development team with three global appointments

Published03/06/2020

Read more

Displaying 12 of 68